The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy.
about
Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanismsThe non-specific effects of vaccines and other childhood interventions: the contribution of INDEPTH Health and Demographic Surveillance SystemsIntroduction of standard measles vaccination in an urban African community in 1979 and overall child survival: a reanalysis of data from a cohort studyLessons and challenges for measles control from unexpected large outbreak, MalawiA randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissionsEffect of early measles vaccine on pneumococcal colonization: A randomized trial from Guinea-Bissau.Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau.Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival.Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges.Severe acute malnutrition and infection.Vaccination and heterologous immunity: educating the immune systemImmunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trialMeasles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of ageAge-appropriate vaccination against measles and DPT-3 in India - closing the gapsSimultaneous vaccination with MMR and DTaP-IPV-Hib and rate of hospital admissions with any infections: A nationwide register based cohort study.The epidemiological characteristics of measles and difficulties of measles elimination in Hang Zhou, ChinaIs early measles vaccination better than later measles vaccination?Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines.Co-administration of BCG and Diphtheria-tetanus-pertussis (DTP) Vaccinations May Reduce Infant Mortality More Than the WHO-schedule of BCG First and Then DTP. A Re-analysis of Demographic Surveillance Data From Rural BangladeshMeasles cases among adolescents in southern Pakistan 2012-2015: The case for revisiting vaccination strategies.Measles virus antibody responses in children randomly assigned to receive standard-titer edmonston-zagreb measles vaccine at 4.5 and 9 months of age, 9 months of age, or 9 and 18 months of age.
P2860
Q26864779-DEBE6D98-E635-45BD-A019-73AB826753FAQ27027641-90F5CDF9-6D1E-4F34-8F9F-39580518EC8FQ28365370-E7C6A06C-A6E2-43C8-B993-33A8B4B057F7Q30223450-34558E4D-33DC-4A79-A4A6-7EA60898F685Q33596061-E517D07A-101D-451E-992C-06F246ED0ECFQ33699031-F8AAD7BD-96D8-47BB-993D-6EEC9922660DQ33868334-7EEB6D90-8ED1-4DD9-AC46-B0E934315CB9Q33953925-D246AA5D-E646-45F8-8AE3-E2828D47ED9AQ34439339-AA6F4217-42A9-48FF-9623-B924FC6F02EEQ34701568-0ADA240E-0336-48E3-9B9D-BF3611BF62A8Q35152750-D9907B02-D780-4F0D-9A70-A140EFFAFC3CQ36053643-2A1BB725-AE3F-48A3-9D82-CDBEEBE79330Q36547324-4FEF6984-5A82-48A9-BBF1-883977DED03AQ36798576-A91B5A58-F831-4A3F-A772-393AA6647409Q37481313-85544BC0-2818-4387-8E8B-58920E6B89B1Q37514780-88DEBE35-1630-4C08-95BF-557E942A6F7FQ38312176-7C4ED08B-CF31-4008-BF53-40CE861856BEQ38543488-87713238-77EB-460A-AE28-D9F5F7C8B61BQ38636400-955B5988-11DB-4A24-A401-3D26A2FA7E5FQ38820913-C67E65A1-4B02-406D-ADF0-247BA322CCECQ42227759-EB5C0552-D132-4D7D-859A-DB54B6AEA773
P2860
The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The optimal age of measles imm ...... underlying the current policy.
@ast
The optimal age of measles imm ...... underlying the current policy.
@en
The optimal age of measles imm ...... underlying the current policy.
@nl
type
label
The optimal age of measles imm ...... underlying the current policy.
@ast
The optimal age of measles imm ...... underlying the current policy.
@en
The optimal age of measles imm ...... underlying the current policy.
@nl
prefLabel
The optimal age of measles imm ...... underlying the current policy.
@ast
The optimal age of measles imm ...... underlying the current policy.
@en
The optimal age of measles imm ...... underlying the current policy.
@nl
P2093
P2860
P1433
P1476
The optimal age of measles imm ...... underlying the current policy.
@en
P2093
Amabelia Rodrigues
Cesário L Martins
Hilton Whittle
May-Lill Garly
P2860
P356
10.1136/BMJOPEN-2011-000761
P577
2012-07-19T00:00:00Z